Dokumendiregister | Terviseamet |
Viit | 13.1-1/24/758-2 |
Registreeritud | 31.01.2024 |
Sünkroonitud | 27.03.2024 |
Liik | Sissetulev dokument |
Funktsioon | 13.1 Kesklabor |
Sari | 13.1-1 Kesklabori kirjavahetus (sh laboriuuringute tellimiskirjad ja protokollid) |
Toimik | 13-1.1/2024 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | EY Consulting BV |
Saabumis/saatmisviis | EY Consulting BV |
Vastutaja | Ilona Honga (TA, Peadirektori asetäitja (2) vastutusvaldkond, Rahvatervise labor, Kesklabor) |
Originaal | Ava uues aknas |
Lp Stella
Palun registreerida e- kiri DHS’s.
Täitmiseks I. Honga, I. Epold.
Lugupidamisega
Jelena Pipper
Saatja: CASP2024 <[email protected]>
Saatmisaeg: kolmapäev, 31. jaanuar 2024 13:23
Teema: Reminder: Request for information – CASP 2024 testing campaign on Disposable electronic cigarettes under a European Commission product safety project
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
Dear Sir/Madam,
This is a kind reminder about the below message. Could you provide us with an answer by next Wednesday 7 February please?
Many thanks in advance,
Best regards,
EY Team
EY Consulting BV Website: http://www.ey.com |
From: CASP2024
Sent: Wednesday, January 17, 2024 7:25 PM
Subject: Request for information – CASP 2024 testing campaign on Disposable electronic cigarettes under a European Commission product safety project
Dear Sir/Madam,
We are contacting you from EY Belgium regarding the project initiated and financed by the European Commission CASP 2024 - Coordinated Activities on the Safety of Products in the EU/EFTA countries. EY is currently supporting the European Commission to enable Market Surveillance Authorities (MSAs) of EU/EFTA countries to test consumer products in a harmonised manner across the Single Market. For further information on this, please refer to the accreditation letter attached to this email. Under this large-scale project, products will be sampled by MSAs in their respective markets and tested against safety requirements in a single accredited testing laboratory located within the EU/EFTA for the purpose of market surveillance.
Your laboratory has been identified using the National Accreditation Body website of your country as being accredited to test disposable electronic cigarettes. According to our research, your laboratory is accredited to ISO/IEC 17025 and to at least to one of the standards, directives or Regulations below.
As we are currently collecting information on eligible laboratories that would be interested and capable of testing disposable electronic cigarettes under the CASP 2024, you are invited to let us know more about your laboratory using the table below.
| Topic | Question | Laboratory answer |
1 | Interest | Is your laboratory interested in participating in the CASP 2024 testing campaign? | |
2 | Eligibility | Is your laboratory accredited to ISO/IEC 17025:2017 and to at least one of the above standards, directives or Regulations? |
|
3 | Scope of accreditation | Can you please confirm for which of the standards, directives or Regulations mentioned above your laboratory is accredited with a valid accreditation certificate? |
|
4 | N° of specimens needed for each sample and test | Could you estimate the number of specimens needed for the same sample to run the various tests? Please be as specific as possible. | |
5 | Initial price estimation | Can you provide a price estimation to test products (per part of the standard)? If you foresee a discount based on volume, please indicate this as well. |
|
6 | Capacity to host lab meeting | We plan to hold a 2-day meeting in the selected laboratory in the period (tentatively) October 2024-January 2025 with 15-20 project participants. The aim of the meeting will be to visit the facility and discuss testing results with laboratory representatives. Is your laboratory able to host such a meeting? |
|
7 | Contact person | Could you provide us the contact details of the person within your organisation dealing with testing/business development? |
|
8 | Additional recommended testing | Is there any additional testing you would recommend to perform for the respective product group? |
|
Given your experience in testing consumer products, it would be valuable for us to know more about your laboratory. We would appreciate an answer from you and your team by Friday 26 January.
Should you need more information, please do not hesitate to reach out to us.
Kind regards,
EY Project Team
EY Consulting BV Website: http://www.ey.com |
___________________________________
The information contained in this communication is intended solely for the use of the individual or entity to whom it is addressed and others authorized to receive it. It may contain confidential or legally privileged information. If you are not the intended recipient you are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by responding to this email and then delete it from your system. EY is neither liable for the proper and complete transmission of the information contained in this communication nor for any delay in its receipt.
Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
---|---|---|---|---|---|---|
Kiri | 12.02.2024 | 44 | 13.1-1/24/758-6 🔒 | Väljaminev dokument | ta | EY Consulting BV |
Kiri | 12.02.2024 | 44 | 13.1-1/24/758-5 | Väljaminev dokument | ta | EY Consulting BV |
Kiri | 07.02.2024 | 49 | 13.1-1/24/758-3 | Sissetulev dokument | ta | EY Project team |
Kiri | 07.02.2024 | 49 | 13.1-1/24/758-4 | Sissetulev dokument | ta | EY Consulting BV |
Päring | 18.01.2024 | 69 | 13.1-1/24/758-1 | Sissetulev dokument | ta | EY Consulting BV |